AZ’s Dato-DXd misses survival endpoint in lung cancer trial
The overall survival (OS) data has come in from the TROPION-Lung01 study of AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan (Dato-DXd) in lung cancer – and the res
Lilly ups spend on diabetes, obesity drug production to $9bn
Eli Lilly is determined not to be left behind when it comes to manufacturing capacity for new diabetes and obesity therapies, raising its spending on a new plant in Indian
NICE, NHS England unveil new pathway for medtech
Feedback is being sought on a proposed pathway that aims to accelerate access to new medical technologies by laying out a common set of rules and commissioning principles.
ASCO: AffyImmune claims a first with CAR-T for solid tumours
AffyImmune Therapeutics has recorded what it says is the first documented complete response in a patient with a solid tumour treated with CAR-T therapy.
ASCO: Merus bispecific garners attention after abstract drop
Among the myriad of new studies highlighted in the newly published ASCO abstracts, Merus’ seems to have struck a chord with its phase 2 trial of bispecific antibody petose
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
Oncology
Patients
R&D
Partner Content
6th Macrophage-Directed Therapies Summit
Unravel Complex Macrophage Biology, Accelerate Novel Target Discovery, & Drive Clinical Proof of Concept to Deliver the Blockbuster Potential of Macrophage Therapeutics in Oncology & Beyond
3rd mRNA Process Development & Manufacturing Summit
Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into
2nd mRNA Quality Control & Compliance Summit
The 2nd mRNA Quality Control & Compliance Summit 2024 returns this June 25-27 (Boston, MA), as the sole industry-centred forum dedicated to showcasing technical data and though
The 9th CAR-TCR Summit Returns to Boston!
The commercial success of cell therapies is continuing to grow!
Word Monster and the PM Society Join Forces to Elevate Medic...
The PM Society and Word Monster are joining forces in a new partnership focusing on raising standards and nurturing talent in the MedComms industry.